Healthcare Value Capital as of Sept. 30, 2015
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 25 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biosante Pharmaceuticals Call Option (ANIP) | 19.2 | $13M | 340k | 39.52 | |
| Albany Molecular Research | 10.0 | $7.0M | 402k | 17.42 | |
| Astrazeneca Sponsored Adr (AZN) | 9.1 | $6.4M | 200k | 31.82 | |
| Qlt | 8.2 | $5.7M | 2.2M | 2.66 | |
| Pfizer (PFE) | 6.7 | $4.7M | 150k | 31.41 | |
| Proshares Tr Ultsht Russ2000 | 6.2 | $4.3M | 100k | 43.38 | |
| Quest Diagnostics Incorporated (DGX) | 5.8 | $4.1M | 66k | 61.47 | |
| MannKind Corporation Put Option | 5.5 | $3.9M | 1.2M | 3.21 | |
| Glaxosmithkline Sponsored Adr Call Option | 5.5 | $3.8M | 100k | 38.45 | |
| CryoLife (AORT) | 5.1 | $3.6M | 370k | 9.73 | |
| Allergan SHS | 3.9 | $2.7M | 10k | 271.80 | |
| Mylan N V Shs Euro Call Option | 2.9 | $2.0M | 50k | 40.26 | |
| Abbvie (ABBV) | 1.9 | $1.4M | 25k | 54.40 | |
| Alliqua Biomedical Com New | 1.9 | $1.3M | 421k | 3.17 | |
| Apricus Bioscience Call Option | 1.6 | $1.1M | 750k | 1.46 | |
| Amarin Corp Spons Adr New Call Option (AMRN) | 1.1 | $772k | 400k | 1.93 | |
| Aegerion Pharmaceuticals | 1.0 | $680k | 50k | 13.60 | |
| Cytokinetics Com New (CYTK) | 1.0 | $669k | 100k | 6.69 | |
| Fibrocell Science Com New | 0.8 | $569k | 148k | 3.85 | |
| Zogenix Com New | 0.6 | $430k | 32k | 13.50 | |
| Sorrento Therapeutics Com New (SRNEQ) | 0.6 | $420k | 50k | 8.40 | |
| Sunesis Pharmaceuticals Com New Call Option | 0.5 | $365k | 450k | 0.81 | |
| Ariad Pharmaceuticals | 0.4 | $292k | 50k | 5.84 | |
| Alimera Sciences | 0.3 | $221k | 100k | 2.21 | |
| D Stemline Therapeutics | 0.3 | $221k | 25k | 8.84 |
